chelerythrine and troglitazone
chelerythrine has been researched along with troglitazone in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
Fowler, R; Friday, E; Nissim, I; Turturro, F; Welbourne, T | 1 |
Other Studies
2 other study(ies) available for chelerythrine and troglitazone
Article | Year |
---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Troglitazone acts by PPARgamma and PPARgamma-independent pathways on LLC-PK1-F+ acid-base metabolism.
Topics: Acid-Base Equilibrium; Acidosis; Alanine; Alkaloids; Animals; Antineoplastic Agents; Benzhydryl Compounds; Benzophenanthridines; Carcinogens; Chromans; Enzyme Inhibitors; Epoxy Compounds; Genes, Reporter; Hydrogen-Ion Concentration; LLC-PK1 Cells; Phenanthridines; Plasmids; Protein Kinase C; Quaternary Ammonium Compounds; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Swine; Thiazolidinediones; Transcription Factors; Troglitazone | 2004 |